GPCR

16.2105.32%
RC

Raymond C. Stevens

CEO & Director

Dr. Raymond C. Stevens, Ph.D. is Professor of Molecular Biology and Chemistry at The Scripps Research Institute, La Jolla, California since 1999 until July 2014. He has been the Chief Executive Officer at Structure Therapeutics Inc. (formerly known as ShouTi, Inc.) since May 2019 and has been its Director since February 2019. Dr. Stevens consults part-time for several biotech companies in the area of structural biology and structure-based drug design. He has helped to pioneer the area of high throughput structural biology, establishing several National Institutes of Health supported structural biology research centers. Dr. Stevens was Co-Founder of RuiYi Inc. and Takeda California, Inc. He served as Scientific Founder of Receptos, Inc. Dr. Stevens was Founder of MemRx Corporation. He is the Chairman of the Scientific Advisory Board at Sagres Discovery, Inc. He serves as a Director of Bird Rock Bio, Inc. (formerly Anaphore, Inc.). He serves as Member of Scientific Advisory Board of ProTherapeutics Pte Ltd. He has been Independent Director of Danaher Corporation since February 21, 2017. He is Founding Director of the iHuman Institute at ShanghaiTech University and has launched multiple biotechnology companies focused on drug discovery. He served as a Member of the Supervisory Board of BioMarin Pharmaceutical Inc., since February 2004. He served as a Director of Receptos, Inc. Dr. Stevens joined Scripps in 1999. Dr. Stevens was Assistant Professor of Chemistry and Neurobiology at the University of California, Berkeley. He serves as Director of Bridge Institute at the University of Southern California, where he has served since July 2014 until August 2021. He holds a Chaired professorship at The Scripps Research Institute in San Diego. Dr. Stevens has published over 150 papers and earned nine patents, focusing primarily on the determination of novel protein structures using X-ray crystallography. He has published more than 240 peer reviewed publications in the past 20 years, focusing primarily in the area of structural biology and structure based drug discovery including involvement in the development of Tamiflu', Kuvan', PEG-PAL' and Alogliptin'. Dr. Stevens received numerous awards in the area of structural biology, including the Sidhu Award (1992), the National Science Foundation's Presidential Young Investigator Award (1994) and the Beckman Foundation's Young Investigator Award (1994). Dr. Stevens obtained his PhD in Chemistry (Nobel Prize, 1994) from the University of Southern California and conducted his post-doctoral research in structural biology with Professor William Lipscomb (Nobel Prize, 1976) at Harvard University. He obtained BS in Chemistry from University of Southern Maine.

Positions